BR9909918A - Método para a liberação de um hormÈnio de crescimento ou citocina de proteìna, peptìdeo ou polipeptìdeo fisiologicamente ativos a um vertebrado não-humano - Google Patents
Método para a liberação de um hormÈnio de crescimento ou citocina de proteìna, peptìdeo ou polipeptìdeo fisiologicamente ativos a um vertebrado não-humanoInfo
- Publication number
- BR9909918A BR9909918A BR9909918-7A BR9909918A BR9909918A BR 9909918 A BR9909918 A BR 9909918A BR 9909918 A BR9909918 A BR 9909918A BR 9909918 A BR9909918 A BR 9909918A
- Authority
- BR
- Brazil
- Prior art keywords
- human vertebrate
- release
- polypeptide
- peptide
- physiologically active
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 102000004127 Cytokines Human genes 0.000 title abstract 2
- 108090000695 Cytokines Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 abstract 3
- 229940088597 hormone Drugs 0.000 abstract 2
- 239000005556 hormone Substances 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
<B>MéTODO PARA A LIBERAçãO DE UM HORMÈNIO DE CRESCIMENTO OU CITOCINA DE PROTEìNA, PEPTìDEO OU POLIPEPTìDEO FISIOLOGICAMENTE ATIVOS A UM VERTEBRADO NãO-HUMANO<D> A presente invenção diz respeito à introdução de moléculas de DNA ou RNA desnudo que codificam hormónios ou citocinas de peptídeos de vertebrados não-humanos em um vertebrado não-humano para se obter a liberação de hormónio ou citocina de peptídeos de vertebrados não-humanos. A invenção fornece, dessa forma, uma alternativa a administração direta do polipeptídeo de interesse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8441898P | 1998-05-06 | 1998-05-06 | |
PCT/US1999/006528 WO1999057275A1 (en) | 1998-05-06 | 1999-04-15 | Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909918A true BR9909918A (pt) | 2000-12-26 |
Family
ID=22184848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909918-7A BR9909918A (pt) | 1998-05-06 | 1999-04-15 | Método para a liberação de um hormÈnio de crescimento ou citocina de proteìna, peptìdeo ou polipeptìdeo fisiologicamente ativos a um vertebrado não-humano |
Country Status (11)
Country | Link |
---|---|
US (1) | US20020111323A1 (pt) |
EP (1) | EP1075520A1 (pt) |
JP (1) | JP2002513811A (pt) |
CN (1) | CN1297481A (pt) |
AU (1) | AU3739999A (pt) |
BR (1) | BR9909918A (pt) |
CA (1) | CA2324650A1 (pt) |
NO (1) | NO20005567D0 (pt) |
PL (1) | PL345241A1 (pt) |
WO (1) | WO1999057275A1 (pt) |
ZA (1) | ZA200005300B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6977245B2 (en) | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
ATE378348T1 (de) | 2000-01-14 | 2007-11-15 | Us Health | Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion |
US7666674B2 (en) | 2001-07-27 | 2010-02-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo |
AU2002361468A1 (en) | 2001-08-14 | 2003-03-18 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human S | Method for rapid generation of mature dendritic cells |
US8466116B2 (en) | 2001-12-20 | 2013-06-18 | The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
US7615227B2 (en) | 2001-12-20 | 2009-11-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce angiogenesis |
US8263091B2 (en) | 2002-09-18 | 2012-09-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides |
DE102007001370A1 (de) | 2007-01-09 | 2008-07-10 | Curevac Gmbh | RNA-kodierte Antikörper |
DK2222697T3 (da) | 2007-11-01 | 2013-03-11 | Perseid Therapeutics Llc | Immunsuppressive polypeptider og nukleinsyrer |
US10799555B2 (en) | 2016-09-15 | 2020-10-13 | Leidos, Inc. | PD-1 peptide inhibitors |
DK3795167T3 (da) | 2016-09-15 | 2022-08-29 | Leidos Inc | Pd-1-peptidinhibitorer |
WO2019168524A1 (en) | 2018-02-27 | 2019-09-06 | Leidos, Inc. | Pd-1 peptide inhibitors |
WO2020237050A1 (en) | 2019-05-22 | 2020-11-26 | Leidos, Inc. | Lag3 binding peptides |
WO2021247789A1 (en) | 2020-06-04 | 2021-12-09 | Leidos, Inc. | Immunomodulatory compounds |
US11578102B2 (en) | 2020-07-31 | 2023-02-14 | Leidos, Inc. | LAG3 binding peptides |
EP4225444A1 (en) | 2020-10-12 | 2023-08-16 | Leidos, Inc. | Immunomodulatory peptides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2092983A (en) * | 1982-11-08 | 1984-05-17 | Genentech Inc. | Porcine growth hormone produced by recombinant dna technology |
US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
DE4303744A1 (de) * | 1993-02-09 | 1994-08-11 | Univ Autonoma De Nuevo Leon Mo | Hundewachstumshormon |
US6225290B1 (en) * | 1996-09-19 | 2001-05-01 | The Regents Of The University Of California | Systemic gene therapy by intestinal cell transformation |
-
1999
- 1999-04-15 CA CA002324650A patent/CA2324650A1/en not_active Abandoned
- 1999-04-15 JP JP2000547230A patent/JP2002513811A/ja active Pending
- 1999-04-15 PL PL99345241A patent/PL345241A1/xx not_active Application Discontinuation
- 1999-04-15 CN CN99805215A patent/CN1297481A/zh active Pending
- 1999-04-15 WO PCT/US1999/006528 patent/WO1999057275A1/en not_active Application Discontinuation
- 1999-04-15 BR BR9909918-7A patent/BR9909918A/pt not_active IP Right Cessation
- 1999-04-15 AU AU37399/99A patent/AU3739999A/en not_active Abandoned
- 1999-04-15 EP EP99919746A patent/EP1075520A1/en not_active Withdrawn
-
2000
- 2000-09-29 ZA ZA200005300A patent/ZA200005300B/xx unknown
- 2000-11-03 NO NO20005567A patent/NO20005567D0/no not_active Application Discontinuation
-
2001
- 2001-07-02 US US09/898,428 patent/US20020111323A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020111323A1 (en) | 2002-08-15 |
ZA200005300B (en) | 2001-10-01 |
NO20005567L (no) | 2000-11-03 |
CN1297481A (zh) | 2001-05-30 |
NO20005567D0 (no) | 2000-11-03 |
AU3739999A (en) | 1999-11-23 |
JP2002513811A (ja) | 2002-05-14 |
WO1999057275A1 (en) | 1999-11-11 |
PL345241A1 (en) | 2001-12-03 |
EP1075520A1 (en) | 2001-02-14 |
CA2324650A1 (en) | 1999-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9909918A (pt) | Método para a liberação de um hormÈnio de crescimento ou citocina de proteìna, peptìdeo ou polipeptìdeo fisiologicamente ativos a um vertebrado não-humano | |
BR0108959A (pt) | Composições de poloxmero ou poloxamina melhoradas para distribuição de ácido nucléico | |
AR018346A1 (es) | Peptidos mutantes promotores de la inmunidad celular t, composiciones farmaceuticas y vacunas formuladas con dichos peptidos para el tratamiento decanceres; uso de dichos peptidos, metodo para identificar dichos peptidos y secuencias de adn que codifican dichos peptidos mutantes y vectores y plasmid | |
CY1111006T1 (el) | Εκριμματαση ασθενειας alzheimer | |
EP1067182A3 (en) | Secretory protein or membrane protein | |
ES2149149T1 (es) | Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion. | |
DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
DE69941701D1 (de) | Mutanten von flt3-l und ihre verwendungen | |
ATE329028T1 (de) | Nl3 tie rezeptortyrosinekinase ligandhomologe | |
EP1508574A3 (en) | Long wavelength engineered fluorescent proteins | |
MXPA04001547A (es) | Proteina de leptina porcina, antisentido y anticuerpo. | |
BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
BR9812791A (pt) | Sequências de ácido nucléico associadas à virulência e seu uso | |
IL145689A0 (en) | Methods | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
BR9510067A (pt) | Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo | |
AU2002341090A1 (en) | Use of a protein of the crmp family for treating diseases related to the immune system | |
WO2002005843A3 (en) | Human rrp sequences and methods of use | |
DK0781344T3 (da) | Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme | |
WO2002026929A3 (en) | Kini-3 motor protein and methods for its use | |
WO2003106650A3 (en) | NUCLEIC ACIDS ENCODING CHD5, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF | |
ES2308850T3 (es) | Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. | |
DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
AU2001280639A1 (en) | 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor | |
CA2348732A1 (en) | Human h37 proteins and cdnas encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O,6O, 7O E 8O ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |